DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$403M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$403M | — |
| 2024 | −$292M | — |
| 2023 | −$188M | — |
| 2022 | −$154M | — |
| 2021 | −$120M | — |
| 2020 | −$47M | — |
| 2019 | −$12M | — |